Tsochatzis EA - Search Results

1

Neuroimaging correlates of brain injury in Wilson's disease: a multimodal, whole-brain MRI study.

Shribman S, Bocchetta M, Sudre CH, Acosta-Cabronero J, Burrows M, Cook P, Thomas DL, Gillett GT, Tsochatzis EA, Bandmann O, Rohrer JD, Warner TT. Shribman S, et al. Among authors: tsochatzis ea. Brain. 2022 Mar 29;145(1):263-275. doi: 10.1093/brain/awab274. Brain. 2022. PMID: 34289020 Free PMC article.

2

Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease.

Shribman S, Heller C, Burrows M, Heslegrave A, Swift I, Foiani MS, Gillett GT, Tsochatzis EA, Rowe JB, Gerhard A, Butler CR, Masellis M, Bremner F, Martin A, Jung L, Cook P, Zetterberg H, Bandmann O, Rohrer JD, Warner TT. Shribman S, et al. Among authors: tsochatzis ea. Mov Disord. 2021 Feb;36(2):503-508. doi: 10.1002/mds.28333. Epub 2020 Oct 20. Mov Disord. 2021. PMID: 33078859 Free PMC article.

3

Neuroimaging Correlates of Cognitive Deficits in Wilson's Disease.

Shribman S, Burrows M, Convery R, Bocchetta M, Sudre CH, Acosta-Cabronero J, Thomas DL, Gillett GT, Tsochatzis EA, Bandmann O, Rohrer JD, Warner TT. Shribman S, et al. Among authors: tsochatzis ea. Mov Disord. 2022 Aug;37(8):1728-1738. doi: 10.1002/mds.29123. Epub 2022 Jun 20. Mov Disord. 2022. PMID: 35723521 Free PMC article.

4

MRE in NAFLD: Promising but Further Validation is Required.

Ryan JD, Tsochatzis EA. Ryan JD, et al. Among authors: tsochatzis ea. Ann Hepatol. 2017 May-Jun;16(3):331-332. doi: 10.5604/16652681.1235474. Ann Hepatol. 2017. PMID: 28425401 Free article.

5

Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study.

Goyale A, Jain A, Smith C, Papatheodoridi M, Misas MG, Roccarina D, Prat LI, Mikhailidis DP, Nair D, Tsochatzis E. Goyale A, et al. PLoS One. 2021 Nov 23;16(11):e0260313. doi: 10.1371/journal.pone.0260313. eCollection 2021. PLoS One. 2021. PMID: 34813621 Free PMC article.

6

Case 21-2016: A Man in an Unresponsive State.

Tsochatzis EA, Papatheodoridis GV. Tsochatzis EA, et al. N Engl J Med. 2016 Oct 27;375(17):1697. doi: 10.1056/NEJMc1610229. N Engl J Med. 2016. PMID: 27783905 Free article. No abstract available.

7

The effect of antidiabetic medications on non-alcoholic fatty liver disease (NAFLD).

Iogna Prat L, Tsochatzis EA. Iogna Prat L, et al. Among authors: tsochatzis ea. Hormones (Athens). 2018 Jun;17(2):219-229. doi: 10.1007/s42000-018-0021-9. Epub 2018 Apr 17. Hormones (Athens). 2018. PMID: 29858843 Review.

8

Establishing Reliability Criteria for Liver ElastPQ Shear Wave Elastography (ElastPQ-SWE): Comparison Between 10, 5 and 3 Measurements.

Roccarina D, Iogna Prat L, Buzzetti E, Guerrero Misas M, Aricó FM, Saffioti F, Rosselli M, Pinzani M, Marshall A, Thorburn D, Tsochatzis E. Roccarina D, et al. Ultraschall Med. 2021 Apr;42(2):204-213. doi: 10.1055/a-1010-6052. Epub 2019 Oct 8. Ultraschall Med. 2021. PMID: 31594008 English.

9

Reply to: "Do we need to re-define the Baveno VI elastography criteria for compensated advanced chronic liver disease (cACLD)?".

Papatheodoridi M, Pinzani M, Tsochatzis E. Papatheodoridi M, et al. J Hepatol. 2021 Sep;75(3):752-753. doi: 10.1016/j.jhep.2021.06.007. Epub 2021 Jun 17. J Hepatol. 2021. PMID: 34146649 No abstract available.

10

Reply to: "Baveno VI elastography criteria for ruling in cACLD works well in patients with MAFLD" and "Transient elastography in chronic liver disease: Beware of the cut-offs!".

Papatheodoridi M, Pinzani M, Tsochatzis E. Papatheodoridi M, et al. J Hepatol. 2021 Nov;75(5):1247. doi: 10.1016/j.jhep.2021.07.036. Epub 2021 Aug 25. J Hepatol. 2021. PMID: 34453965 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page